N/A N=7 Dual-task Augmented Reality for PD DBS
Parkinson's Disease · Deep Brain Stimulation
Primary: Movement Disorder Society Unified Parkinson's Disease Rating Scale Part III: Motor Examination Score — 3.25 Score on a scale
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=35 Gut Organoid and Microbiome Interactions in Hypertension
Gut Inflammation · Hypertension
Primary: Differential Gene Expression in Gut Epithelium — 29; 6 Differentially expressed gene
N/A N=29 A Comparative Assessment of Transfemoral Prosthetic Sockets
Amputation · Amputation; Traumatic, Leg, Lower
Primary: Socket Fit Comfort Score — 7.0; 7.4; 7.9; 7.3 units on a scale — p=0.553
N/A N=60 Efficacy of Gamification in Enhancing User Engagement
Alzheimer Disease · Dementia · Gamification
Primary: Change in User Interaction and Engagement From Baseline to 6 Months — 32; 60; 7; 36 Uses per Month
N/A N=92 Intervention Effectiveness Towards Improving Physical and Mental Health for Post-stroke Patients.
Stroke · Brain Infarction · Brain Ischemia
Primary: Changes From Baseline Patient Health Questionnaire at 1, 3, and 6 Months — 10.9; 10.3; 9.1; 19.7 units on a scale — p=<0.05
Phase 4 N=150 Effects on the Pain of an Infiltration by Acid Hyaluronic Association and Corticoids Versus Only Corticoids in the Rhizarthrosis.
Rhizarthrosis
Primary: Analogical Visual Scale of Pain (VAS) — -1.66; -2.65 centimeter
Phase 1 N=40 Single Ascending Doses of Kratom in Healthy Nondependent Adults With Opioid Experience
Safety · Pharmacokinetics · Pharmacodynamics
Primary: Number of Participants With Treatment-Emergent Adverse Events (TEAEs) — 1; 1; 5; 4 Participants
Phase 1 N=40 Ketones, Muscle Metabolism, and SGLT2 Inhibitors - Protocol 1
Heart Failure · Type 2 Diabetes Mellitus
Primary: Cardiac Output (CO) — 5.02; 4.54; 5.93; 5.10 mL/min
N/A N=320 OP5-005 Using Omnipod 5 in Adults With Type 2
Type2 Diabetes
Primary: Change in HbA1c — 8.2; 7.4 Percentage of HbA1C
N/A N=1,600 Testing Strategies for Couple Engagement in PMTCT and Family Health in Kenya
Human Immunodeficiency Virus
Primary: Number of Couples Who Tested for HIV as a Couple After Study Enrollment up to 12 Months Postpartum — 114; 106; 26 Couples tested for HIV as a couple (=Y) — p=<0.001
N/A N=175 PREPP: Preventing Postpartum Depression
Postpartum Depression (PPD)
Primary: Score on the Edinburgh Postnatal Depression Scale (EPDS) — 5.04; 4.36; 4.43; 4.04 score on a scale
N/A N=85 A Quality Improvement Process to Support Delivery of Cardiovascular Care in Community Mental Health Organizations
Diabetes Mellitus · Hypertension · Dyslipidemias
Primary: Quality Improvement Culture as Assessed by the Modified Version of the Validated Survey on Patient Safety — 3.8; 3.8 score on a scale
N/A N=283 The Study of CYP2C19 Genotype-Guided Clopidogrel Treatment Models
Coronary Artery Disease · Clopidogrel Resistance · Coronary Thrombosis
Primary: Number of Study Participants Who Died From Any Cause (Death From Any Cause) — 8; 2; 7 Participants
N/A N=80 Efficacy of Family Constellations in the General Population
Mild to Moderate Psychopathological Symptoms
Primary: Change in Brief Symptom Inventory Scores — 0.61; 0.71 score on a scale
N/A N=27 A Relative Bioavailability Study of Nicotine Delivery From Selected Oral Nicotine Products
Healthy Volunteers
Primary: Nicotine Cmax — 14.98; 13.43; 19.35; 13.85 ng/mL